These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17142340)

  • 21. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.
    de las Heras N; Martín-Fernández B; Miana M; Ballesteros S; Oubiña MP; López-Farré AJ; Cachofeiro V; Lahera V
    J Hypertens Suppl; 2009 Aug; 27(6):S37-41. PubMed ID: 19633450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of PPARgamma in myocardial infarction.
    Fliegner D; Westermann D; Riad A; Schubert C; Becher E; Fielitz J; Tschöpe C; Regitz-Zagrosek V
    Eur J Heart Fail; 2008 Jan; 10(1):30-8. PubMed ID: 18162196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
    Leenen FH; Yuan B
    Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
    Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
    Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
    Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
    Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats.
    Di Filippo C; Lampa E; Tufariello E; Petronella P; Freda F; Capuano A; D'Amico M
    Obes Res; 2005 Nov; 13(11):1909-14. PubMed ID: 16339122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
    de Beer VJ; Sorop O; Pijnappels DA; Dekkers DH; Boomsma F; Lamers JM; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2069-77. PubMed ID: 18310517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
    Nap A; Balt JC; Pfaffendorf M; Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of irbesartan on nitric oxide system in the heart of diabetic rats].
    Qian XX; Chen YM; Wu WK; Liu Y; Zhou B; Liu JL; Chen L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1359-62. PubMed ID: 16982456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.
    Hayashi M; Takeshita K; Uchida Y; Yamamoto K; Kikuchi R; Nakayama T; Nomura E; Cheng XW; Matsushita T; Nakamura S; Murohara T
    PLoS One; 2014; 9(12):e116163. PubMed ID: 25551221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction.
    Merkus D; Haitsma DB; Sorop O; Boomsma F; de Beer VJ; Lamers JM; Verdouw PD; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2082-9. PubMed ID: 16798821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.